Cancer Frontline

April 2013
Archive

"Cancer is a complex and heterogeneous disease driven by gene
mutations. As we enter the era of personalized medicine, the
characterization of the cancer genome has begun and will continue to
influence diagnostic and therapeutic decisions in the clinic."

So begins Timothy Heffernan, Ph.D., associate director of target
discovery at the Institute for Applied Cancer Science (IACS), in an
article discussing how cancer genome discoveries...